Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

October 04, 2015 11:40 AM ET


Company Overview of Adamas Pharmaceuticals, Inc.

Key Executives for Adamas Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Gregory T. Went Ph.D.28 RelationshipsChairman and Chief Executive Officer51
William J. Dawson 6 RelationshipsChief Financial Officer60
Jeffrey H. Knapp No RelationshipsChief Operating Officer49
Natalie L. McClure Ph.D.No RelationshipsSenior Vice President of Product Development62
Rajiv Patni M.D.No RelationshipsChief Medical Officer46

Adamas Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Gregory T. Went Ph.D. 28 RelationshipsAdamas Pharmaceuticals, Inc.51
David L. Mahoney 44 RelationshipsAdamas Pharmaceuticals, Inc.61
Richard H. Booth CPA, CLU, ChFC 74 Relationships1347 Capital Corp.68
Martha J. Demski 53 RelationshipsAjinomoto Althea, Inc.62
William W. Ericson J.D. 142 RelationshipsMohr Davidow Ventures56
View All Board Members

Adamas Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Martha J. Demski53 Relationships3 Executives
Compensation Committee CPA, CLU, ChFCRichard H. Booth74 Relationships3 Executives
Nominating Committee David L. Mahoney44 Relationships3 Executives
Corporate Governance Committee David L. Mahoney44 Relationships3 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation
Not meaningful
Total Value of Options$748.8K
Compensation as of Fiscal Year 2014
Adamas Pharmaceuticals, Inc. CEO Compensation
Industry Average


SC Johnson Appoints Ann Mukherjee as Global Chief Marketing Officer
October 02, 2015 12:00 AM ET
Spectrum Brands Holdings, Inc. Announces Changes to the Board of Directors
September 28, 2015 12:00 PM ET
Mary Agnes Wilderotter Does Not Stand for Re-Election to Board of Directors of The Procter & Gamble Company
September 25, 2015 8:00 PM ET
The National Detergent Company S.A.O.G. Announces Board Changes
September 21, 2015 7:50 AM ET
Procter & Gamble Announces Retirement of Tarek Farahat as President of Latin America Selling and Market Operations
September 18, 2015 4:32 PM ET

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Adamas Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at